Re: Amarin Market Cap
|
4
|
Resverlogix Corp.
|
Jul 08, 2019 12:51PM
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
6
|
Resverlogix Corp.
|
Jul 08, 2019 12:37PM
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
3
|
Resverlogix Corp.
|
Jul 08, 2019 09:54AM
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
8
|
Resverlogix Corp.
|
Jul 08, 2019 09:36AM
|
Re: ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?
|
5
|
Resverlogix Corp.
|
Jul 06, 2019 12:47PM
|
Re: ERA-EDTA 2019 Symposium: Vascular calcification in kidney disease: Epigenetics as a novel approach?
|
9
|
Resverlogix Corp.
|
Jul 05, 2019 04:46PM
|
ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?
|
7
|
Resverlogix Corp.
|
Jul 05, 2019 04:20PM
|
Re: Market Cap Context
|
8
|
Resverlogix Corp.
|
Jul 05, 2019 10:54AM
|
Re: Upcoming PR
|
10
|
Resverlogix Corp.
|
Jul 03, 2019 08:06PM
|
Re: Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
5
|
Resverlogix Corp.
|
Jul 03, 2019 10:32AM
|
Re: Just a thought - Should we really be expecting maximum exposure for BETonMACE results?
|
7
|
Resverlogix Corp.
|
Jul 02, 2019 09:56PM
|
Re: No ESC 2019 Late Breaker
|
5
|
Resverlogix Corp.
|
Jul 02, 2019 02:28PM
|
Re: Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
4
|
Resverlogix Corp.
|
Jul 02, 2019 12:58PM
|
Re: No ESC 2019 Late Breaker
|
3
|
Resverlogix Corp.
|
Jul 02, 2019 12:27PM
|
Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
5
|
Resverlogix Corp.
|
Jul 02, 2019 11:59AM
|
Re: No ESC 2019 Late Breaker
|
6
|
Resverlogix Corp.
|
Jul 02, 2019 10:44AM
|
Re: No ESC 2019 Late Breaker
|
4
|
Resverlogix Corp.
|
Jul 02, 2019 09:42AM
|
Re: No ESC 2019 Late Breaker
|
5
|
Resverlogix Corp.
|
Jul 01, 2019 08:38PM
|
Re: RRR %
|
1
|
Resverlogix Corp.
|
Jul 01, 2019 05:42PM
|
Re: I'm not watching super close....
|
3
|
Resverlogix Corp.
|
Jul 01, 2019 05:36PM
|